Clinical Trials Directory

Trials / Completed

CompletedNCT03203434

Non-invasive Detection of Anastomotic Leakage

Non-invasive Detection of Anastomotic Leakage Following Esophageal and Pancreatic Surgery by Urinary Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Amsterdam UMC, location VUmc · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Esophagectomy or pancreaticoduodenectomy is the standard surgical approach for patients with malignant tumors of the esophagus or pancreatic head. These procedures are associated with high morbidity rates, which are strongly correlated with the occurrence of anastomotic leakage. Current diagnostic methods, including clinical, biochemical and radiological techniques are frequently inconclusive. Delay in diagnosis leads to delay in treatment, which ratifies the need for development of novel and accurate non-invasive diagnostic tests for detection of anastomotic leakage. Urinary volatile organic compounds reflect the metabolic status of an individual, which is associated with a systemic immunological response. The aim of this study was to determine the diagnostic accuracy of urinary volatile organic compounds to detect anastomotic leakage after esophagectomy or pancreaticoduodenectomy in an early phase.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUrinary volatile organic compound analysis

Timeline

Start date
2015-01-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2017-06-29
Last updated
2017-07-02

Source: ClinicalTrials.gov record NCT03203434. Inclusion in this directory is not an endorsement.